POINT PREVALENCE SURVEY OF ANTIMICROBIAL CONSUMPTION IN A TERTIARY CARE HOSPITAL OF NORTH EAST INDIA

MUKUNDAM BORAH; DWIPEN KHANIKAR; SHASHANKA SHEKHAR CHAKRABORTY; ANANGA CHARKRABORTY; DIPTIMAYEE DEVI; VIBHOR DUDHRAJ; ARTI BAHL

doi:10.22159/ijpps.2024v16i12.52442

Authors

MUKUNDAM BORAH Department of Pharmacology, Gauhati Medical College, Guwahati, Assam, India https://orcid.org/0009-0004-6092-7710
DWIPEN KHANIKAR Department of Pharmacology, Gauhati Medical College, Guwahati, Assam, India https://orcid.org/0000-0002-6648-1068
SHASHANKA SHEKHAR CHAKRABORTY Department of Community Medicine, Tezpur Medical College, Tezpur, Assam, India https://orcid.org/0000-0001-7740-3607
ANANGA CHARKRABORTY Quality Consultant, District Health Society, Goalpara, Assam, India https://orcid.org/0009-0005-6162-4874
DIPTIMAYEE DEVI Department of Pharmacology, Gauhati Medical College, Guwahati, Assam, India
VIBHOR DUDHRAJ Research associate, National Centre for Disease Control (NCDC), India https://orcid.org/0000-0001-9661-1030
ARTI BAHL Additional Director and HOD, Epidemiology Division, NCDC, India https://orcid.org/0000-0003-0123-8558

DOI:

https://doi.org/10.22159/ijpps.2024v16i12.52442

Keywords:

Point prevalence survey, Antibiotic consumption, Antimicrobial stewardship

Abstract

Objective: The study was conducted to quantify antimicrobial utilization and determine the patterns of antibiotic use in Indoor patients and ICUs of the hospital.

Methods: The Point Prevalent Survey (PPS) was conducted in a core “National Antimicrobial Consumption Network site” as a part of the National Centre for Disease Control-WHO project “Point prevalence survey of antimicrobial consumption at healthcare facilities.” The study was conducted as per the “WHO Methodology for PPS on Antibiotic use in hospitals” in March, 2022. Altogether, 1396 eligible patients were admitted during the survey period, and 1109 patients were included in the survey. Data were collected using a predesigned and pretested questionnaire in separate hospital, ward and patient forms.

Results: The prevalence of antibiotic use during the study was 79.44%. On an average, 1.39 antibiotics were in use per patient and only a minor fraction of (1.5%) patients received definitive therapy. Parenteral route of administration (92.72%) was mostly used for administration of antibiotics. The most common indication for antibiotic use was found to be surgical prophylaxis (30.66%). There were 154 antibiotic prescriptions in the 'Not Recommended' category. Double gram negative and double anaerobic cover accounted for 25% and 8.3% respectively of the total prescriptions.

Conclusion: Empirical use of antibiotics is common and lack of utilisation of antimicrobial susceptibility testing services requires urgent interventions. Routine monitoring of antibiotic use is recommended to improve the current scenario of antimicrobial consumption.

Downloads

Download data is not yet available.

References

Taneja N, Sharma M. Antimicrobial resistance in the environment: the Indian scenario. Indian J Med Res. 2019 Feb;149(2):119-28. doi: 10.4103/ijmr.IJMR_331_18, PMID 31219076, PMCID PMC6563737.

Shallcross LJ, Howard SJ, Fowler T, Davies SC. Tackling the threat of antimicrobial resistance: from policy to sustainable action. Philos Trans R Soc Lond B Biol Sci. 2015 Jun 5;370(1670):20140082. doi: 10.1098/rstb.2014.0082, PMID 25918440, PMCID PMC4424432.

Rice LB. Antimicrobial stewardship and antimicrobial resistance. Med Clin North Am. 2018 Sep;102(5):805-18. doi: 10.1016/j.mcna.2018.04.004, PMID 30126572.

Al Omari A, Al Mutair A, Alhumaid S, Salih S, Alanazi A, Albarsan H. The impact of antimicrobial stewardship program implementation at four tertiary private hospitals: results of a five years pre-post analysis. Antimicrob Resist Infect Control. 2020 Jun 29;9(1):95. doi: 10.1186/s13756-020-00751-4, PMID 32600391, PMCID PMC7322716.

Karuniawati H, Yulianti T, Aini DK, Nurwienda FI. Impact of antimicrobial stewardship program on the use of antibiotics in pneumonia patients at teaching hospital in Surakarta Indonesia. Int J App Pharm. 2021;13(1):20-3. doi: 10.22159/ijap.2021.v13s1.Y0067.

Pauwels I, Versporten A, Vermeulen H, Vlieghe E, Goossens H. Assessing the impact of the global point prevalence survey of antimicrobial consumption and resistance (GLOBAL-PPS) on hospital antimicrobial stewardship programmes: results of a worldwide survey. Antimicrob Resist Infect Control. 2021 Sep 28;10(1):138. doi: 10.1186/s13756-021-01010-w, PMID 34583775, PMCID PMC8478001.

Ankrah D, Owusu H, Aggor A, Osei A, Ampomah A, Harrison M. Point prevalence survey of antimicrobial utilization in ghanas premier hospital: implications for antimicrobial stewardship. Antibiotics (Basel). 2021 Dec 14;10(12):1528. doi: 10.3390/antibiotics10121528, PMID 34943740, PMCID PMC8698913.

World Health Organization. WHO methodology for point prevalence survey on antibiotic use in hospitals; 2019. Available from: https://www.who.int/publications/i/item/WHO-EMP-IAU-2018.01.

OO WT, Carr SD, Marchello CS, San MM, OO AT, OO KM. Point prevalence surveys of antimicrobial consumption and resistance at a paediatric and an adult tertiary referral hospital in Yangon Myanmar. Infect Prev Pract. 2022;4(1):100197. doi: 10.1016/j.infpip.2021.100197, PMID 35005602.

Fentie AM, Degefaw Y, Asfaw G, Shewarega W, Woldearegay M, Abebe E. Multicentre point prevalence survey of antibiotic use and healthcare associated infections in Ethiopian hospitals. BMJ Open. 2022 Feb 11;12(2):e054541. doi: 10.1136/bmjopen-2021-054541, PMID 35149567, PMCID PMC8845215.

Elhajji FD, Al Taani GM, Anani L, Al Masri S, Abdalaziz H, Qabbah SH. Comparative point prevalence survey of antimicrobial consumption between a hospital in Northern Ireland and a hospital in Jordan. BMC Health Serv Res. 2018;18(1):849. doi: 10.1186/s12913-018-3656-y, PMID 30419895, PMCID PMC6233602.

WHO. World health organization collaborating centre for drug statistics methodology ATC/DDD index 2023. Geneva: WHO collaborating centre for drug statistics methodology; 2013. Available from: https://www.whocc.no/atc_ddd_index. [Last accessed on 12 Oct 2009].

WHO. The 2021 WHO aware classification of antibiotics for evaluation and monitoring of use. World Health Organization; 2021. Available from: https://www.who.int/publications/i/item/2021-aware-classification.

Sheikh S, Vishwas G, Aggarwal M, Bhattacharya S, Kumari P, Parashar L. Antibiotic point prevalence survey at a tertiary healthcare hospital in India: identifying strategies to improve the antibiotic stewardship program immediately after a COVID-19 wave. Infect Prev Pract. 2022 Dec;4(4):100253. doi: 10.1016/j.infpip.2022.100253, PMID 36276168, PMCID PMC9562613.

Fazaludeen Koya S, Ganesh S, Selvaraj S, Wirtz VJ, Galea S, Rockers PC. Antibiotic consumption in India: geographical variations and temporal changes between 2011 and 2019. JAC Antimicrob Resist. 2022 Oct 26;4(5):dlac112. doi: 10.1093/jacamr/dlac112, PMID 36320447, PMCID PMC9596537.

Haque M. Antimicrobial use prescribing and resistance in selected ten selected developing countries: a brief overview. Asian J Pharm Clin Res. 2017;10(8):37-45. doi: 10.22159/ajpcr.2017.v10i8.19468.

Panditrao AM, Shafiq N, Chatterjee S, Pathak A, Trivedi N, Sadasivam B. A multicentre point prevalence survey (PPS) of antimicrobial use amongst admitted patients in tertiary care centres in India. J Antimicrob Chemother. 2021 Mar 12;76(4):1094-101. doi: 10.1093/jac/dkaa533, PMID 34244744.

Ogunleye OO, Oyawole MR, Odunuga PT, Kalejaye F, Yinka Ogunleye AF, Olalekan A. A multicentre point prevalence study of antibiotics utilization in hospitalized patients in an urban secondary and a tertiary healthcare facilities in Nigeria: findings and implications. Expert Rev Anti Infect Ther. 2022 Feb;20(2):297-306. doi: 10.1080/14787210.2021.1941870, PMID 34128756.

Saleem Z, Hassali MA, Versporten A, Godman B, Hashmi FK, Goossens H. A multicenter point prevalence survey of antibiotic use in Punjab Pakistan: findings and implications. Expert Rev Anti Infect Ther. 2019 Apr;17(4):285-93. doi: 10.1080/14787210.2019.1581063, PMID 30755077.

Kumar S, Shukla P, Goel P, Mishra V, Gupta A, Karuna T. Point prevalence study (PPS) of antibiotic usage and bacterial culture rate (BCR) among secondary care hospitals of small cities in central India: consolidating Indian evidence. J Lab Physicians. 2023 Feb 9;15(2):259-63. doi: 10.1055/s-0042-1757585, PMID 37323604, PMCID PMC10264115.

Singh SK, Sengupta S, Antony R, Bhattacharya S, Mukhopadhyay C, Ramasubramanian V. Variations in antibiotic use across India: multi centre study through global point prevalence survey. J Hosp Infect. 2019 Nov;103(3):280-3. doi: 10.1016/j.jhin.2019.05.014, PMID 31170422.

Dhole S, Mahakalkar C, Kshirsagar S, Bhargava A. Antibiotic prophylaxis in surgery: current insights and future directions for surgical site infection prevention. Cureus. 2023 Oct 28;15(10):e47858. doi: 10.7759/cureus.47858, PMID 38021553, PMCID PMC10680052.

Global guidelines for the prevention of surgical site infection geneva: world health organization; 2018. Web appendix 25 summary of a systematic review on surgical antibiotic prophylaxis prolongation. Available from: https://www.ncbi.nlm.nih.gov/books/NBK536429.

Anugulruengkitt S, Charoenpong L, Kulthanmanusorn A, Thienthong V, Usayaporn S, Kaewkhankhaeng W. Point prevalence survey of antibiotic use among hospitalized patients across 41 Hospitals in Thailand. JAC Antimicrob Resist. 2023 Jan 4;5(1):dlac140. doi: 10.1093/jacamr/dlac140, PMID 36628340, PMCID PMC9825250.

Veerapa Mangroo LP, Rasamoelina Andriamanivo H, Issack MI, Cardinale E. Point prevalence survey on antibiotic use in the hospitals of Mauritius. Front Antibiot. 2023;1:1-9. doi: 10.3389/frabi.2022.1045081.

Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014 Dec;5(6):229-41. doi: 10.1177/2042098614554919, PMID 25436105, PMCID PMC42325.